Beam Therapeutics

Beam Therapeutics is committed to providing lifelong cures to patients suffering from serious diseases through gene-based editing. It creates precision genetic medicines with base editing, developing and optimizing this technology to build a broad pipeline of investigational precision genetic medicines. Beam has a growing portfolio of proprietary gene editing technologies, including a cytosine base editor and an adenine base editor.